Metraipolis › archive › dc_ac0ff5d0d148
Pharmacological Activity of Kaurenoic Acid Nanocarriers and Formulation Considerations for Therapeutic Cancer Applications — Europe PMC PMID:42076089
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42076089
- DOI
- 10.3390/pharmaceutics18040437
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T14:05:01.698Z
- SHA-256 of the archived text
14052012ebb510d7bebda78df765990bf06ae18da32c8ee71f5b4f0d9eedcc29- Stable URL of this page
https://metraipolis.com/documento/dc_ac0ff5d0d148
How to cite
Pharmacological Activity of Kaurenoic Acid Nanocarriers and Formulation Considerations for Therapeutic Cancer Applications — Europe PMC PMID:42076089 — Europe PMC (en), https://europepmc.org/article/MED/42076089 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac0ff5d0d148 (Metraipolis archive dc_ac0ff5d0d148, sha256 14052012ebb510d7bebda78df765990bf06ae18da32c8ee71f5b4f0d9eedcc29)
BibTeX
@misc{dcac0ff5d0d148,
title = {Pharmacological Activity of Kaurenoic Acid Nanocarriers and Formulation Considerations for Therapeutic Cancer Applications — Europe PMC PMID:42076089},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42076089},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac0ff5d0d148; sha256 14052012ebb510d7bebda78df765990bf06ae18da32c8ee71f5b4f0d9eedcc29},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42076089. Agents can read the archived copy with the MCP tool read_document.